Almirall, S.A. ( LBTSF) - Stock Earnings
LBTSF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 24, 2026, midnight | — / — | — | — / — | — |
LBTSF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 5.9 million USD | 323.4 million USD |
| 2025Q3 | 14.7 million USD | 305.4 million USD |
| 2025Q4 | 8.3 million USD | 344.4 million USD |
LBTSF Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -42.5 million USD | 988.8 million USD |
| 2024 | 10.6 million USD | 1.0 billion USD |
| 2025 | 54.2 million USD | 1.3 billion USD |
LBTSF
Price: $15.35
Dividend Yield: 1.34%
Forward Dividend Yield: 1.34%
Dividend Per Share: 0.21 USD
Earnings Per Share: 0.26 USD
P/E Ratio: 59.04
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 3.3 billion
Average Dividend Frequency: 1
Years Paying Dividends: 8
DGR3: 2.16%
DGR5: 11.69%